Clinical Biochemistry, Год журнала: 2025, Номер unknown, С. 110927 - 110927
Опубликована: Апрель 1, 2025
Язык: Английский
Clinical Biochemistry, Год журнала: 2025, Номер unknown, С. 110927 - 110927
Опубликована: Апрель 1, 2025
Язык: Английский
Frontiers in Immunology, Год журнала: 2025, Номер 16
Опубликована: Янв. 31, 2025
Objective Insomnia is increasingly recognized as a significant factor in the development of various autoimmune diseases, including uveitis (AU). We investigated insomnia-associated genes that may contribute to AU pathogenesis and sought identify potential biomarkers for AU. Methods Microarray data related insomnia were downloaded from Gene Expression Omnibus (GEO) database analyzed. The GEO2R tool was used differentially expressed (DEGs) common between Weighted gene co-expression network analysis (WGCNA), protein-protein interaction (PPI), functional enrichment, CMap analyses then performed pathogenic genes, underlying mechanisms, therapeutic drugs Least absolute shrinkage selection operator regression employed screen candidate biomarkers, their diagnostic performance evaluated using receiver operating characteristic (ROC) curves quantitative polymerase chain reaction (qPCR). Finally, molecular docking applied verify binding activities. Results identified 138 up-regulated 85 down-regulated DEGs PPI highlighted 10 key 30 compounds, WGCNA revealed 54 compounds. Intersection above-mentioned compounds six five After verification by qPCR ROC curve analysis, IFI44 IRF9 confirmed hub genes. two selected based on scores less than −7 kcal/mol. Conclusion Our study demonstrated involvement viral response both significance these conditions. These findings provide novel insights future strategies treat
Язык: Английский
Процитировано
0Clinical Biochemistry, Год журнала: 2025, Номер unknown, С. 110927 - 110927
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0